Peritoneal dialysis: an underutilized modality.

Current Opinion in Nephrology and Hypertension
Sirin JiwakanonRajnish Mehrotra

Abstract

There have been differential changes in outcomes of patients treated with in-center hemodialysis and peritoneal dialysis. In light of these changes, providers and practices should reevaluate the utilization of peritoneal dialysis. Accumulating evidence confirms that the present distribution of dialysis modality in the United States does not reflect patient choice. Furthermore, in most recent cohorts, the 5-year adjusted survival of patients treated with hemodialysis and peritoneal dialysis is remarkably similar (35 and 33% respectively). Similar results have been reported from Canada, Australia, and New Zealand. Moreover, health-related quality of life of peritoneal dialysis patients are no different from that reported by those treated with nocturnal hemodialysis. Finally, an expansion of use of peritoneal dialysis for the treatment of end-stage renal disease makes economic sense for the taxpayers - the payors for dialysis services. The improvement in outcomes of peritoneal dialysis patients makes a compelling argument for the expansion of the use of the therapy for the treatment of end-stage renal disease in the United States. We think that 20-40% of patients can be treated with peritoneal dialysis. However, any expansion in u...Continue Reading

References

Oct 22, 2003·Journal of the American Society of Nephrology : JASN·Fabian TermorshuizenUNKNOWN Netherlands Cooperative Study on the Adequacy of Dialysis Study Group
Dec 1, 2006·Kidney International·Y S LiemW C Winkelmayer
Feb 1, 2007·Kidney International·M J OliverB J Manns
Feb 3, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Christian VergerJean-Philippe Ryckelynck
Sep 7, 2007·Journal of the American Society of Nephrology : JASN·Rajnish MehrotraAllen Nissenson
Oct 12, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Edwin FongChristopher T Chan
Oct 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Osman KhawarRajnish Mehrotra
Feb 5, 2008·Health Policy·Paul Michael JustFrank de Charro
Aug 30, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·David C MendelssohnFredric O Finkelstein
Sep 23, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·David W JohnsonKathryn J Wiggins
Dec 19, 2008·Journal of the American Society of Nephrology : JASN·Stephen P McDonaldKevan R Polkinghorne
Apr 3, 2009·Kidney International·Rajnish MehrotraEdward Vonesh
May 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Helmut Schiffl
Jun 6, 2009·Contributions to Nephrology·Johan V Povlsen
Sep 5, 2009·Clinical Journal of the American Society of Nephrology : CJASN·David W JohnsonKathryn J Wiggins
Feb 6, 2010·Journal of the American Society of Nephrology : JASN·Eric D WeinhandlAllan J Collins

❮ Previous
Next ❯

Citations

Jul 19, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Mitchell H Rosner
Jan 12, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Lilia R LukowskyKamyar Kalantar-Zadeh
Nov 20, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Rohini ArramreddyLeslie Wong
Aug 21, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Betty K ChuiScott W Klarenbach
May 9, 2012·International Journal of Nursing Studies·Lori Harwood, Alexander M Clark
Feb 22, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Rajnish Mehrotra
Jul 27, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Rajnish Mehrotra
Jan 5, 2016·International Urology and Nephrology·Konstadina GrivaMarjorie Foo
Feb 15, 2011·Néphrologie & thérapeutique·Cécile CouchoudUNKNOWN Groupe de Travail REIN « Dialyse Péritonéale »
Feb 4, 2012·Journal of Advanced Nursing·Lori HarwoodAlexander M Clark
Mar 22, 2014·Journal of Clinical Nursing·Lori Harwood, Alexander M Clark
May 25, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Martin J Andersen, Allon N Friedman
Dec 1, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Kunal ChaudharyRamesh Khanna
Aug 2, 2014·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Frank Xiaoqing LiuAlex Yu
Dec 14, 2018·Clinical Kidney Journal·Francisco Rodríguez-EsparragónNicanor Vega-Díaz
Apr 21, 2018·Seminars in Dialysis·Rory F McQuillan, Charmaine E Lok
Dec 1, 2017·Statistics in Biosciences·Douglas LehmannYi Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Seminars in Nephrology
Scott Klarenbach, Braden J Manns
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
David C MendelssohnFredric O Finkelstein
© 2021 Meta ULC. All rights reserved